Target intelligence / Profile preview

Transuranium and heavy metal ions

Molecular classification
Metal ion, Inorganic toxin, Radionuclide
01

Overview

Transuranium metal ions (e.g., plutonium, americium, curium) and other heavy metal ions (e.g., lead, mercury, arsenic) are exogenous toxic substances that pose significant health risks through environmental exposure or radiological accidents (StatPearls, 2023). These ions do not have a physiological role but instead exert toxicity by mimicking essential minerals, binding to functional groups of proteins (like sulfhydryl groups), and inducing oxidative stress (PubMed, PMC4427717). Transuranic elements are particularly hazardous due to their long biological half-lives and alpha-particle emission, which can lead to internal radiation damage and bone-seeking behavior (CDC, 2018). Therapeutic intervention involves the use of chelating agents, which are drugs designed to sequester these ions into stable, non-toxic complexes for renal or fecal excretion (FDA, 2004). Effective chelation therapy is critical for reducing the body burden of these metals and preventing long-term complications such as organ failure, neurological deficits, and carcinogenesis (NIH, 2022).

Other names
ActinidesRadionuclidesToxic metal ionsHeavy metalsTransuranic elements
02

Mechanism of action

Chelation therapy: the drugs act as polydentate ligands that form stable, ring-structured coordination complexes with the metal ions, rendering them chemically inert and facilitating their excretion via the kidneys or bile (StatPearls, 2023).

03

Biological functions

Inhibition of sulfhydryl-containing enzymesInduction of reactive oxygen species (ROS)Disruption of calcium signalingDNA damage via ionizing radiation or oxidative stress
04

Disease associations

Heavy metal poisoningInternal radionuclide contaminationNephropathyNeurotoxicityHematological disorders
05

Safety considerations

Depletion of essential endogenous metals (e.g., zinc, magnesium)Nephrotoxicity from metal-chelator complexesMetal redistribution to the central nervous systemHypocalcemia (associated with EDTA)
06

Interacting drugs

Pentetate calcium trisodium

7 more in the full profile.

07

Biomarkers

Blood metal concentration24-hour urinary metal excretionWhole-body radiation countingSerum creatinine

Beyond the preview

Go deeper on Transuranium and heavy metal ions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transuranium and heavy metal ions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call